Publications

DateDescription
22 October 2013Demonstration of a high level of cross reactivity between different strains of salmonid alphavirus: results from experimental and field studies.Dr David Graham and Dr Marian McLoughlin Salmon Pancreas Disease  Virus  (SPDV), also referred to as  Salmonid  alphavirus (SAV),  causes pancreas disease (PD) in Atlantic salmon and sleeping disease ...
15 May 2013Strong evidence that PD vaccination is helping to control pancreas disease (PD) in European farmed Atlantic salmon.A recent extensive study comparing Pancreas Disease (PD) vaccinated and unvaccinated farmed Atlantic salmon (Salmo salar) populations in the PD (SAV3) endemic zone in Norway has shown that PD  vaccination ...
1 January 2013Latest Update and Implications of the Emergence of Salmon Pancreas Disease Virus subtype 2 in NorwayDr Marian McLoughlin & Dr David Graham & Dr Petter Frost, January 2012There are two distinct genotypic branches of SAV subtype 2 (SAV 2) currently recognised from sequencing data. There is the ...
27 June 2012Merck Animal Health Debuts New Technical Materials to Support Successful SLICE Sustainability ProjectBOXMEER (The Netherlands), June 27, 2012 - Merck Animal Health (known as MSD Animal Health outside the United States and Canada) recently introduced new educational tools and reference materials to support ...
10 June 2012Introducing the SLICE® Sustainability ProjectThe SLICE® Sustainability Project is a global initiative by the Aquatic Animal Health business of MSD Animal Health, the world’s leading animal health company for aquaculture.
9 June 2012Bioassay protocol for in vitro determination of sea lice sensitivity to emamectin benzoateFor in vitro determination of sea lice sensitivity to emamectin benzoate. Bioassays are an important tool for determining the sensitivity of sea lice to treatments. They can be used routinely throughout ...
8 June 2012Guidelines for sampling of feed medicated with SLICE® (emamectin benzoate)Proper manufacture of medicated feeds and administration of the correct dosage are essential to help ensure successful treatment of fish, prevent sub-optimal drug delivery and minimize pressure for the ...
7 June 2012Best-practice treatment principles: Sea lice resistance managementIn September 2000, Merck Animal Health published a technical bulletin entitled Sea Lice Resistance Management (with particular reference to avermectins)...
6 June 2012Stability of emamectin benzoate in methanol stock solution at three different temperaturesBioassays are increasingly being used as a tool to predict sensitivity or to detect changes in sensitivity of sea lice to available sea lice treatments; methods are available for conducting bioassays ...
5 June 2012SLICE® Evaluating ResultsMonitoring results with SLICE® at a Scottish salmon farm.In 2010, MSD Animal Health launched the SLICE® Sustainability Project (SSP), a program designed to help the global salmon industry develop sustainable ...
4 June 2012SLICE® Modified Feed AssayImproved SLICE® medicated-feed assay method.SLICE® (emamectin benzoate, 0.2% w/w) medicated premix is a parasiticide indicated for the treatment and prevention of sea lice infestations in salmonids. Preformed ...
3 June 2012SLICE® Evaluating Results Monitoring results with SLICE® at a Scottish salmon farmThe SLICE® Sustainability Project (SSP), launched by MSD Animal Health in 2010, is designed to help the global salmon industry develop sustainable sea lice control programs including SLICE®. SLICE (emamectin ...
2 June 2012SLICE® Technical MonographSLICE® is a feed premix containing the avermectin, emamectin benzoate, in a 0.2% formulation for the control of sea lice (Lepeophtheirus salmonis and Caligus spp.) on salmon and trout.
1 June 2012SLICE® Usage GuidelinesThis document is a general reference guide about the use of SLICE in Atlantic salmon and trout. It is intended for fish farmers and prescribing veterinarians and has been updated to take into account ...
1 February 2012Streptococcus agalactiae Biotipo II, un gran problema para el cultivo de tilapiaUno de los principales problemas de salud que aquejan a la industria es la estreptococosis causada por la bacteria Streptococcus agalactiae Biotipo II, infección que causa pérdidas significativas pues ...
The publications listed here may contain information on veterinary pharmaceutical and biological products based on international registration dossiers. They may also refer to products that are either not available in your country or are marketed under a different tradename. In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for further information.